References
- Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1-2, 19–25. https://doi.org/https://doi.org/10.1016/j.softx.2015.06.001
- Athanasiadis, E., Cournia, Z., & Spyrou, G. (2012). ChemBioServer: A web-based pipeline for filtering, clustering and visualization of chemical compounds used in drug discovery. Bioinformatics (Oxford, England)), 28(22), 3002–3003. https://doi.org/https://doi.org/10.1093/bioinformatics/bts551
- Baell, J. B., & Holloway, G. A. (2010). New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. Journal of Medicinal Chemistry, 53(7), 2719–2740. https://doi.org/https://doi.org/10.1021/jm901137j
- Berendsen, H. J. C., Berendsen, H. J. C., Postma, J. P. M., Van Gunsteren, W. F., Dinola, A., & Haak, J. R. (1984). Molecular-Dynamics with Coupling to An External Bath Simulations of interfacial systems View project Density Matrix Evolution View project Molecular dynamics with coupling to an external bath Molecular dynamics with coupling to an external bath. The Journal of Chemical Physics, 81(8), 3684–3690. https://doi.org/https://doi.org/10.1063/1.448118
- Berthold, M. R., Cebron, N., Dill, F., Gabriel, T. R., Kötter, T., Meinl, T., Ohl, P., Thiel, K., & Wiswedel, B. (2009). KNIME - the Konstanz information miner. ACM SIGKDD Explorations Newsletter, 11(1), 26–31. https://doi.org/https://doi.org/10.1145/1656274.1656280
- Bianchini, G., Balko, J. M., Mayer, I. A., Sanders, M. E., & Gianni, L. (2016, November). Triple-negative breast cancer: Challenges and opportunities of a heterogeneous disease. Nature Reviews. Clinical Oncology, 13(11), 674–690. https://doi.org/https://doi.org/10.1038/nrclinonc.2016.66
- Coughlin, K., Anchoori, R., Iizuka, Y., Meints, J., MacNeill, L., Vogel, R. I., Orlowski, R. Z., Lee, M. K., Roden, R. B. S., & Bazzaro, M. (2014). Small-molecule RA-9 inhibits proteasome-associated DUBs and ovarian cancer in vitro and in vivo via exacerbating unfolded protein Responses. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 20(12), 3174–3186. https://doi.org/https://doi.org/10.1158/1078-0432.CCR-13-2658
- Dallakyan, S., & Olson, A. J. (2015). Small-molecule library screening by docking with PyRx. Methods in Molecular Biology (Clifton, N.J.).), 1263, 243–250. https://doi.org/https://doi.org/10.1007/978-1-4939-2269-7_19
- Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N ⋅log (N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98(12), 10089–10092. https://doi.org/https://doi.org/10.1063/1.464397
- De, P., Sun, Y., Carlson, J. H., Friedman, L. S., Leyland-Jones, B. R., & Dey, N. (2014). Doubling down on the PI3k-AKT-mTOR pathway enhances the antitumor efficacy of PARP inhibitor in triple negative breast cancer model beyond BRCA-ness. Neoplasia (New York, N.Y.), ), 16(1), 43–72. https://doi.org/https://doi.org/10.1593/neo.131694
- Gong, B., Cao, Z., Zheng, P., Vitolo, O. V., Liu, S., Staniszewski, A., Moolman, D., Zhang, H., Shelanski, M., & Arancio, O. (2006). Ubiquitin Hydrolase Uch-L1 Rescues beta-amyloid-induced decreases in synaptic function and contextual memory. Cell, 126(4), 775–788. https://doi.org/https://doi.org/10.1016/j.cell.2006.06.046
- Halgren, T. A. (1996). Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. Journal of Computational Chemistry, 17(5-6), 490–519.https://doi.org/https://doi.org/10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P
- Hess, B., Bekker, H., Berendsen, H. J. C., & Fraaije, J. G. E. M. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18(12), 1463–1472. https://doi.org/https://doi.org/10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
- Hirayama, K., Aoki, S., Nishikawa, K., Matsumoto, T., & Wada, K. (2007). Identification of novel chemical inhibitors for ubiquitin C-terminal hydrolase-L3 by virtual screening. Bioorganic & Medicinal Chemistry, 15(21), 6810–6818. https://doi.org/https://doi.org/10.1016/j.bmc.2007.07.016
- Issaenko, O. A., & Amerik, A. Y. (2012). Chalcone-based small-molecule inhibitors attenuate malignant phenotype via targeting deubiquitinating enzymes. Cell Cycle (Georgetown, Tex.).), 11(9), 1804–1817. https://doi.org/https://doi.org/10.4161/cc.20174
- Kondapaka, S. B., Singh, S. S., Dasmahapatra, G. P., Sausville, E. A., & Roy, K. K. (2003). Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation. Molecular Cancer Therapeutics, 2(11), 1093–1103.
- Kumari, R., Kumar, R., Lynn, A., & Lynn, A. (2014). g_mmpbsa-a GROMACS tool for high-throughput MM-PBSA calculations . Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/https://doi.org/10.1021/ci500020m
- Ledermann, J., Harter, P., Gourley, C., Friedlander, M., Vergote, I., Rustin, G., Scott, C. L., Meier, W., Shapira-Frommer, R., Safra, T., Matei, D., Fielding, A., Spencer, S., Dougherty, B., Orr, M., Hodgson, D., Barrett, J. C., & Matulonis, U. (2014). Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: A preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial. The Lancet Oncology, 15(8), 852–861. https://doi.org/https://doi.org/10.1016/S1470-2045(14)70228-1
- Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46(1-3), 3–26. https://doi.org/https://doi.org/10.1016/S0169-409X(00)00129-0
- Liu, Y., Lashuel, H. A., Choi, S., Xing, X., Case, A., Ni, J., Yeh, L.-A., Cuny, G. D., Stein, R. L., & Lansbury, P. T. (2003). Discovery of inhibitors that elucidate the role of UCH-L1 activity in the H1299 lung cancer cell line. Chemistry & Biology, 10(9), 837–846. https://doi.org/https://doi.org/10.1016/j.chembiol.2003.08.010
- Luo, K., Li, L., Li, Y., Wu, C., Yin, Y., Chen, Y., Deng, M., Nowsheen, S., Yuan, J., & Lou, Z. (2016). A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination. Genes & Development, 30(23), 2581–2595. https://doi.org/https://doi.org/10.1101/gad.289439.116
- Maier, J. A., Martinez, C., Kasavajhala, K., Wickstrom, L., Hauser, K. E., & Simmerling, C. (2015). ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. Journal of Chemical Theory and Computation, 11(8), 3696–3713. https://doi.org/https://doi.org/10.1021/acs.jctc.5b00255
- Mermerian, A. H., Case, A., Stein, R. L., & Cuny, G. D. (2007). Structure-activity relationship, kinetic mechanism, and selectivity for a new class of ubiquitin C-terminal hydrolase-L1 (UCH-L1) inhibitors. Bioorganic & Medicinal Chemistry Letters, 17(13), 3729–3732. https://doi.org/https://doi.org/10.1016/j.bmcl.2007.04.027
- Mistry, H., Hsieh, G., Buhrlage, S. J., Huang, M., Park, E., Cuny, G. D., Galinsky, I., Stone, R. M., Gray, N. S., D'Andrea, A. D., & Parmar, K. (2013). Small-Molecule inhibitors of usp1 target id1 degradation in leukemic cells. Molecular Cancer Therapeutics, 12(12), 2651–2662. https://doi.org/https://doi.org/10.1158/1535-7163.MCT-13-0103-T
- Molecular Operating Environment (MOE) (2020). https://www.chemcomp.com/Products.htm
- Mysinger, M. M., Carchia, M., Irwin, J. J., & Shoichet, B. K. (2012). Directory of useful decoys, enhanced (DUD-E): Better ligands and decoys for better benchmarking. Journal of Medicinal Chemistry, 55(14), 6582–6594. https://doi.org/https://doi.org/10.1021/jm300687e
- O'Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open Babel: An Open chemical toolbox. Journal of Cheminformatics, 3(10), 33https://doi.org/https://doi.org/10.1186/1758-2946-3-33
- Ohayon, S., Spasser, L., Aharoni, A., & Brik, A. (2012). Targeting deubiquitinases enabled by chemical synthesis of proteins. Journal of the American Chemical Society, 134(6), 3281–3289. https://doi.org/https://doi.org/10.1021/ja2116712
- O'Shaughnessy, J., Schwartzberg, L., Danso, M. A., Miller, K. D., Rugo, H. S., Neubauer, M., Robert, N., Hellerstedt, B., Saleh, M., Richards, P., Specht, J. M., Yardley, D. A., Carlson, R. W., Finn, R. S., Charpentier, E., Garcia-Ribas, I., & Winer, E. P. (2014). Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer. J. Clin. Oncol, 32(34), 3840–3847. https://doi.org/https://doi.org/10.1200/JCO.2014.55.2984
- Pan, M., Zheng, Q., Ding, S., Zhang, L., Qu, Q., Wang, T., Hong, D., Ren, Y., Liang, L., Chen, C., Mei, Z., & Liu, L. (2019). Chemical Protein Synthesis Enabled Mechanistic Studies on the Molecular Recognition of K27-linked Ubiquitin Chains. Angewandte Chemie (International ed. in English), 58(9), 2627–2631. https://doi.org/https://doi.org/10.1002/anie.201810814
- Parrinello, M., & Rahman, A. (1981). Polymorphic transitions in single crystals: A new molecular dynamics method. Journal of Applied Physics, 52(12), 7182–7190. https://doi.org/https://doi.org/10.1063/1.328693
- Shah, S. P., Roth, A., Goya, R., Oloumi, A., Ha, G., Zhao, Y., Turashvili, G., Ding, J., Tse, K., Haffari, G., Bashashati, A., Prentice, L. M., Khattra, J., Burleigh, A., Yap, D., Bernard, V., McPherson, A., Shumansky, K., Crisan, A., … Aparicio, S. (2012). The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature, 486(7403), 395–399. https://doi.org/https://doi.org/10.1038/nature10933
- Song, Z., Tu, X., Zhou, Q., Huang, J., Chen, Y., Liu, J., … Lou, Z. (2019). A novel UCHL3 inhibitor, perifosine, enhances PARP inhibitor cytotoxicity through inhibition of homologous recombination-mediated DNA double strand break repair. Cell Death and Disease, 10(6), 1–9. https://doi.org/https://doi.org/10.1038/s41419-019-1628-8
- Trott, O., & Olson, A. J. (2009). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), NA–NA. https://doi.org/https://doi.org/10.1002/jcc.21334
- Tung, N. M., & Garber, J. E. (2018). BRCA1/2 testing: Therapeutic implications for breast cancer management. British Journal of Cancer, 119(2), 141–152. July 17). https://doi.org/https://doi.org/10.1038/s41416-018-0127-5
- Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004). Development and testing of a general Amber force field. Journal of Computational Chemistry, 25(9), 1157–1174. https://doi.org/https://doi.org/10.1002/jcc.20035
- Wang, J., Wang, W., Kollman, P., & Case, D. A.(2001). Antechamber: an accessory software package for molecular mechanical calculations. Citeseer. http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.620.422&rep=rep1&type=pdf
- Ward, A., Khanna, K. K., & Wiegmans, A. P. (2015, January). Targeting homologous recombination, new pre-clinical and clinical therapeutic combinations inhibiting RAD51. Cancer Treatment Reviews, 41(1), 35–45. https://doi.org/https://doi.org/10.1016/j.ctrv.2014.10.006
- Zeichner, S. B., Terawaki, H., & Gogineni, K. (2016, March). A review of systemic treatment in metastatic triple-negative breast cancer. Breast Cancer : basic and Clinical Research, 10, 25–36. https://doi.org/https://doi.org/10.4137/BCBCR.S32783